Patient guide
Reproductive Gene Screening vs. Carrier Screening: Why They're Not the Same Test
Reticular Team
Patient Education
"I already did carrier screening — isn't that the genetic test?" It is a fair question, and the answer is one of the most useful distinctions in reproductive genetics. Carrier screening and reproductive-gene screening sound like the same thing, but they are built to answer two different questions.
The short answer
Carrier screening asks: could a future child inherit a known genetic condition, like cystic fibrosis? Reproductive-gene screening asks a different question: is there a genetic reason a pregnancy might not develop in the first place? The first is about the health of a child who is born; the second is about whether an egg matures, an embryo develops, and a pregnancy continues.
What carrier screening is for
Carrier screening checks whether you carry a recessive variant for well-known inherited conditions — cystic fibrosis, spinal muscular atrophy, sickle cell disease, and others. The logic is about a future child: if both partners carry a variant in the same recessive gene, a child could inherit two copies and be affected (ACOG, Carrier Screening). It is designed around conditions that appear in a person after birth.
That is genuinely valuable information — but notice what it is not asking. It is not asking whether an egg can mature, whether an embryo can make its earliest developmental handoffs, or whether a pregnancy can be maintained. Those questions are about a different set of genes entirely.
What reproductive-gene screening is for
Reproductive-gene screening focuses on genes needed for fertility, embryo development, and pregnancy viability — including maternal-effect genes like TUBB8, NLRP7, and PADI6 that act in the egg and earliest embryo. The question here is not "what could a born child inherit" but "is there a genetic reason development stalls or a pregnancy is lost." Many of these genes never make it onto a carrier-screening panel, because carrier screening was designed for a different purpose.
The overlap is smaller than people expect
This is not just a conceptual difference; it shows up in the gene lists themselves. When the peer-reviewed Human Intolerome — a catalog of genes tied to prenatal and neonatal viability — compared its recessive genes with a standard 112-condition carrier-screening list, only 45 of 566 overlapped (Human Intolerome, Genetics in Medicine, 2026). In other words, the two tests are mostly looking at different genes. Doing one tells you little about what the other would find.
| Carrier screening | Reproductive-gene screening | |
|---|---|---|
| Core question | Could a future child inherit a known condition? | Is there a genetic reason a pregnancy may not develop? |
| Focus | Recessive conditions in a born child (e.g. cystic fibrosis) | Fertility, embryo development, pregnancy viability |
| Example genes | CFTR, SMN1, HBB | TUBB8, NLRP7, PADI6 |
| Gene overlap | Limited — 45 of 566 recessive viability genes appeared on a standard carrier list | |
Which test do you actually need?
Find out in 2 minutes →Why this matters after a loss
If you have had recurrent loss or repeated early embryo arrest and were told your carrier screening was normal, that result was answering the "future child" question — not the "can a pregnancy develop" question. A normal carrier screen is reassuring on its own terms, but it does not close the door on a reproductive-gene cause, any more than a normal karyotype does.
Where Reticular fits
Reticular's parent-only screen is a reproductive-gene screen, not a carrier screen. It is meant to sit alongside carrier screening, not replace it — the two examine largely different genes for largely different reasons, and a finding on either is information to interpret with a genetic counselor rather than a diagnosis. For a fuller comparison with chromosome testing, see Karyotype vs. Reproductive Gene Panel, and for the panel itself, see The Reticular Infertility & Pregnancy Loss Panel.
FAQ
Common questions
Carrier screening asks whether a future child could inherit a known recessive condition, like cystic fibrosis. Reproductive-gene screening asks whether there is a genetic reason a pregnancy might not develop at all, focusing on genes for fertility, embryo development, and pregnancy viability. They answer different questions and mostly examine different genes.
Possibly, if you have had recurrent loss or repeated early embryo arrest. A normal carrier screen answers the 'future child' question, not the 'can a pregnancy develop' question. The two tests examine largely different genes, so a normal result on one says little about what the other would find. Discuss it with a clinician or genetic counselor.
Mostly no. The two tests are built for different questions and look at largely different genes — in one comparison, only a small fraction of pregnancy-viability genes appeared on a standard carrier-screening list. So a normal carrier screen does not tell you much about this layer.
No. They serve different purposes and are meant to sit alongside each other. Reproductive-gene screening does not replace carrier screening, a karyotype, or the standard recurrent-loss evaluation, and a finding is information to weigh with your care team rather than a diagnosis.
See if screening fits your situation.
Compare one- and two-partner plans and what each one includes.